carteolol has been researched along with Atrial Fibrillation in 2 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We herein report an elderly patient with CKD who suffered bradycardia shock after the combined use of carteolol eye drops and verapamil for glaucoma and paroxysmal AF." | 8.02 | Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease. ( Akutsu, N; Arai, R; Fukamachi, D; Monden, M; Murata, N; Okumura, Y, 2021) |
| "The results are summarized of 13 published investigations of the beta-blocker 5-(3-tert-butylamino-2-hydroxy-propoxy)-3, 4-dihydro-2(1H)-quinolinone hydrochloride (carteolol hydrochloride, Endak, Endak mite) with a total of 378 patients suffering from cardiac rhythm irregularities (tachycardias, extrasystoles (ES), arrhythmias)." | 7.66 | [Clinical results with carteolol in patients with arrhythmias]. ( Strösser, W, 1983) |
| " We herein report an elderly patient with CKD who suffered bradycardia shock after the combined use of carteolol eye drops and verapamil for glaucoma and paroxysmal AF." | 4.02 | Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease. ( Akutsu, N; Arai, R; Fukamachi, D; Monden, M; Murata, N; Okumura, Y, 2021) |
| "The results are summarized of 13 published investigations of the beta-blocker 5-(3-tert-butylamino-2-hydroxy-propoxy)-3, 4-dihydro-2(1H)-quinolinone hydrochloride (carteolol hydrochloride, Endak, Endak mite) with a total of 378 patients suffering from cardiac rhythm irregularities (tachycardias, extrasystoles (ES), arrhythmias)." | 3.66 | [Clinical results with carteolol in patients with arrhythmias]. ( Strösser, W, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, R | 1 |
| Fukamachi, D | 1 |
| Monden, M | 1 |
| Akutsu, N | 1 |
| Murata, N | 1 |
| Okumura, Y | 1 |
| Strösser, W | 1 |
2 other studies available for carteolol and Atrial Fibrillation
| Article | Year |
|---|---|
Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease.
Topics: Aged; Atrial Fibrillation; Bradycardia; Carteolol; Humans; Japan; Ophthalmic Solutions; Renal Insuff | 2021 |
[Clinical results with carteolol in patients with arrhythmias].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Carteolol; Heart Rate; Humans; Hyperthyroidism; Propanola | 1983 |